Amine salts of (-)-2-{`2-(4-hydroxyphenyl) ethyl!-thio}-3-`4-(2-{4-`(methylsulfonyl)o xy! phenoxy}ethyl)phenyl! propanoic acid and there use in medicine
Details for Australian Patent Application No. 2004249483 (hide)
International Classifications
Event Publications
12 January 2006 PCT application entered the National Phase
PCT publication WO2004/113283 Priority application(s): WO2004/113283
17 August 2006 Amendment Made
The nature of the amendment is: Amend the invention title to read Amine salts of (-)-2-{[2-(4-hydroxyphenyl)ethyl]-thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]ph enoxy}ethyl)phenyl] propanoic acid and there use in medicine
31 August 2006 Corrigenda
Amendments, Section 104 - Amendments Made Under the name AstraZeneca AB, Application No. 2004249483, under INID (54), correct the title to Amine salts of (-)-2-{[2-(4-hydroxyphenyl)ethyl]-thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl] propanoic acid and their use in medicine
22 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004249477-Chinazoline derivatives as aurora kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser